Reasons for a constructive outlook for European REITs.
Insights
Our latest thinking on the themes shaping today’s investment landscape. Explore timely updates, quarterly features and in-depth analysis straight from our experts.
AI integration and regional dynamics offer a fresh perspective for global small caps.
How pharmaceutical tariffs and drug pricing reform could help secure biopharma innovation over the long run.
Key takeaways from the US-EU trade deal for investors.
In a world of constant change, the key to investment success lies in combining duration and innovation.
The doubling of Japanese sovereign bond yields over the past year could have negative ramifications for government issuers around the word.
Implications of the US-Japan tariff deal for Japanese stocks.
In this episode, we explore how Janus Henderson is navigating geopolitical uncertainty and fostering partnerships for a brighter future.
As AI makes inroads into healthcare, opportunities for patients and investors grow.
With the Fed not certain how to navigate the potential impact of tariffs, we discuss how investors might be inviting undue risk within bond portfolios.
Healthcare is the largest sector within the Collateralised Loan Obligation (CLO) universe. How can CLO investors navigate this environment?